skip to Main Content

Leading Edge Technology for Pathogen Detection

As Seen In:

At Y2X Life Sciences, we believe there is an urgent need for new technologies that combat and control infectious diseases

Since 2000, the world has experienced more than 74 pandemics and epidemics, including COVID-19, SARS, MERS, Ebola, and Swine Flu

Yet our ability to detect airborne pathogens is still in dire need of new technologies and innovation.

Leading-Edge Technologies to Detect Aerosolized Pathogens

  • Signed Options Agreement: Technology developed by WashU that immediately detects SARS-CoV-2 and other pathogens in people and spaces
  • Funded research: Through NIH RADx Initiative Grant
  • Purpose: Create biosensors that substantially reduce large-scale infectious disease testing times, and costs, and improve aerosolized pathogen detection sensitivity and specificity.  Create biodetector devices which are inexpensive, easy to operate, and provide results in under 60 seconds with the accuracy of qPCR.


Y2X Life Sciences actively engages in groundbreaking research and development for disrupting the transmission of infectious diseases.

The result is innovative technologies that bring about faster recoveries from pandemics like Covid-19, and have the potential to limit the scope and spread of future pandemics and epidemics.

Visit the About page to meet our extensive team of Y2X Life Sciences leaders, consultants, and advisors

Read about groundbreaking research and development and cutting edge technologies

Back To Top